Abstract
Background Thoracic aortic dissection is a life-threatening condition that often occurs in the presence of aortic dilation. Despite a known association between ascending aortic diameter (AscAoD) and dissection risk, predicting dissection risk remains challenging.
Objectives Determine whether common variant genetics can be used to improve identification of individuals most at risk for dissection.
Methods A genome wide association study (GWAS)-by-subtraction was performed to characterize the diameter-independent genetics of thoracic aortic dissection by subtracting a GWAS of aortic diameter (AoD) from a GWAS of thoracic aortic aneurysm and dissection (TAAD). A polygenic risk score (PRS) was calculated using the PRS-Continuous Shrinkage statistical package and evaluated for its ability to predict aortic dissection. The primary analytic cohort was Penn Medicine Biobank (PMBB) which comprises volunteers consenting to linkage of health records with biospecimens, including DNA which has undergone genome-wide genotyping; additional analyses were performed in the National Institutes of Health All of Us (AoU) cohort.
Results We identified 43 significant genetic risk loci in our GWAS-by-subtraction and derived a “Dissection-PRS.” In the PMBB, the Dissection-PRS associated with an increased risk of prevalent dissection (odds ratio [OR]=2.13 per 1 standard deviation [sd] increase in Dissection-PRS, 95% confidence interval [CI] 1.91 to 2.39, P<0.001), These results were consistent when excluding individuals with pathogenic or likely pathogenic variants in established aortopathy genes. When adjusting for clinical risk factors including ascending aortic diameter, the association of the Dissection-PRS with prevalent dissection attenuated but remained significant (OR=1.62 per 1 sd increase in PRS, 95% CI 1.36 to 1.94, P<0.001). The addition of the PRS to a model containing age, sex, clinical risk factors, and ascending aortic diameter substantially improved model discrimination (base model area under the receiver operator characteristic curve [AUROC]=0.676, 95% CI 0.651 to 0.702; with addition of PRS AUROC=0.723, 95% CI 0.702 to 0.744). Analysis in AoU demonstrated similar findings.
Conclusions A common-variant PRS can predict aortic dissection in a diverse population.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
J.D. is supported by the American Heart Association (23POST1011251). The views expressed in this article are those of the authors and do not necessarily reflect the position or policy of the Department of Veterans Affairs or the United States government. W.R.W. is supported by NIH R01 HL171709, P41 EB029460, and R01 HL169378. D.M.M. and D.C.G. are supported by the NIH (R01HL109942), the John Ritter Foundation. M.G.L. received support from the Doris Duke Foundation (2023-0224) and Department of Veterans Affairs Biomedical Research and Development Award IK2-BX006551. J.P.P is supported by the NIH (K08HL159346).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The IRB of the University of Pennsylvania gave ethical approval for the Penn Medicine Biobank analysis in this work (Protocol #813913). The IRB of University of California San Francisco gave ethical approval for the All of Us analysis in this work (Protocol #22-37715).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
↵# These authors jointly supervised the work
Abbreviations
- AoD
- Aortic diameter
- AscAoD
- Ascending aortic diameter
- AUROC
- Area under the receiver operator characteristic curve
- CI
- Confidence interval
- CT
- Computed tomography
- CRF
- Clinical Risk Factors
- DesAoD
- Descending aortic diameter
- PRS
- Polygenic risk score
- ROC
- Receiver operator characteristic curve
- SEM
- Structural equation modeling
- TAAD
- Thoracic aortic aneurysm and dissection
- TTE
- Transthoracic echocardiography
